Target intelligence / Profile preview

Intracellular enzymes

Molecular classification
Enzyme, Kinase, Protease, Polymerase, Dehydrogenase
01

Overview

Intracellular enzymes" encompass a vast array of proteins that catalyze biochemical reactions inside cells. These enzymes play crucial roles across all aspects of cellular function, including metabolism, signaling, DNA/RNA processing, protein modification, and cell survival. Therapeutically, they are attractive drug targets both for inhibition (as with many cancer or antiviral drugs) and activation/replacement (as in enzyme replacement therapy for genetic metabolic disorders). Because intracellular enzymes are not exposed on the cell surface, delivering drugs or therapeutic proteins to these targets poses considerable drug development challenges, requiring specialized delivery systems and careful consideration of specificity, toxicity, and immunogenicity. "Intracellular enzymes" is an umbrella term, not a specific target. It covers a large, diverse molecular class fundamental to cell biology and medicine, but it is too broad and unspecific for structured data tied to a single canonical entity. For structured information, reference should be made to a specific enzyme (e.g., "Ornithine transcarbamylase," "Alpha-galactosidase A," "Tyrosine kinase") rather than to the entire broad class.

02

Mechanism of action

Inhibition of enzymatic activity; Replacement of missing/deficient enzyme (ERT); Stabilization of misfolded enzyme (chaperone therapy); Targeted protein degradation; Prodrug activation (enzyme-prodrug therapy); Catalytic modification of substrates inside the cell.

03

Biological functions

MetabolismSignal transductionCell cycleApoptosisDNA/RNA synthesis and repairProtein modificationCellular stress response
04

Disease associations

CancerMetabolic diseases (e.g., lysosomal storage disorders)Neurodegenerative diseaseCardiovascular diseaseInfectionInflammationGenetic disorders
05

Safety considerations

Off-target effects/toxicityImmunogenicityCellular delivery challengesUnintended metabolic disturbancesDrug-drug interactions
06

Interacting drugs

Small-molecule inhibitors (kinase inhibitors, protease inhibitors, polymerase inhibitors)

3 more in the full profile.

07

Biomarkers

Enzyme activity levels in tissues or biofluidsSubstrate/product accumulationGenetic mutations in specific enzyme-encoding genes

Beyond the preview

Go deeper on Intracellular enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call